Pulmonary embolism (PE) is a serious condition where a blood clot, usually from the legs, travels to the lungs and blocks blood flow. It can happen to anyone, but is more common in people who are immobile, have had surgery, or have certain medical conditions. Prompt diagnosis and treatment are crucial to prevent serious complications or death.
Pulmonary embolism (PE) is a potentially fatal condition caused by obstruction of the pulmonary vasculature by an embolus, most commonly a thrombus originating from deep vein thrombosis (DVT). It leads to impaired gas exchange, hemodynamic compromise, and can result in right ventricular strain or failure.
| Condition | Distinguishing Feature |
|---|---|
| Pneumonia | Often associated with fever, productive cough, and focal consolidation on chest X-ray, whereas PE typically presents with pleuritic pain and hypoxemia without clear infiltrates. |
| Pneumothorax | Characterized by sudden onset dyspnea and pleuritic chest pain, but often with decreased breath sounds on the affected side and a visible pleural line on imaging. |
| Acute Coronary Syndrome (ACS) | Chest pain can be similar, but ACS is typically associated with exertional angina, ST-segment changes on ECG, and elevated cardiac biomarkers, rather than pleuritic pain and hypoxemia. |
| Pericarditis | Chest pain is often positional and relieved by sitting up, and ECG may show diffuse ST elevation and PR depression, unlike the segmental changes seen in PE. |
| Pulmonary Hypertension | While PE can cause pulmonary hypertension, primary pulmonary hypertension is a chronic condition with progressive dyspnea and right heart failure symptoms, often without acute exacerbations of pleuritic pain or hemoptysis. |
| Aortic Dissection | Characterized by sudden, severe, tearing chest or back pain and often associated with neurological deficits or pulse deficits, distinct from the pleuritic pain of PE. |
Management focuses on anticoagulation to prevent further clot formation and allow the body to lyse existing clots, with consideration for thrombolysis or embolectomy in hemodynamically unstable patients. Risk stratification is crucial to guide treatment intensity and duration.